四肢組織拡張器の世界市場-2022-2029

市場力学

四肢組織拡張器の世界市場の成長は、技術の進歩、先天性奇形の発生率の上昇、火傷や外傷の増加といった特定の要因に牽引されるもので、市場成長を促進する主要な要因のひとつです。

整形手術の増加により、予測期間中、四肢組織拡張剤の世界市場を牽引すると予想される

米国形成外科学会（ASPS）の最新データによると、2018年、米国で実施された1590万件の美容的低侵襲手術のうち、ボツリヌス毒素A型が744万件でトップとなっています。21世紀初頭には、多くの先進的な非外科的・低侵襲的な美容施術が開発されました。ケアの質が向上し、専門的なサービスが改善され、高い技能を持つ美容外科医による低侵襲手術が可能になったことが、処置件数の増加に寄与しています。

米国形成外科学会によると、2019年に米国で行われた低侵襲美容外科手術および外科手術は約1,750万件でした。北米では、National Clearinghouse of Plastic Surgery Procedural Statistics 2019によると、美容乳房手術は、2016年に行われた外科手術と比較して、2019年に行われた手術の数が4.8％増加しました。

米国美容整形外科学会（ASAPS）は、2019年の米国女性の乳房縮小手術は256,800件、乳房リフト手術は約100,614件と推定しています。米国癌協会（ACS）は、2019年に米国の女性の間で278,361件の浸潤性乳癌が新たに診断されると予測し、乳房注入は美容外科の分野で重要な手術と見なされています。美容外科の動向は、四肢組織拡張器にプラスの範囲を提供します。再建手術や美容手術の外科医の数も時間の経過とともに増加しており、四肢組織拡張器市場の成長も後押しすることになるでしょう。

厳しい規制当局の承認が四肢組織拡張器市場の成長を阻む

しかし、四肢組織拡張器の採用に関連する厳しい規制当局の承認やガイドライン、高い治療費が、予測期間中のこの市場の成長を妨げる要因の一部となっています。

産業分析

四肢組織拡張器の世界市場は、ポーターの5力分析、サプライチェーン分析、規制分析、臨床試験、価格分析、アンメットニーズなど、さまざまな産業要因に基づく市場の詳細な分析を提供します。

セグメント別分析

乳房再建セグメントは予測期間中（2022-2029年）に最も速いCAGRで成長すると予想されます。

乳房再建セグメントは、予測期間中に最も速い成長率で成長すると予想されます。乳がんは、女性の主要ながんの1つであり、がん組織を除去するために乳房切除術が必要となります。WHOによると、乳がんは女性の間で最も頻度の高いがんで、毎年210万人の女性に影響を与えており、また、女性の間で最も多くのがん関連死亡を引き起こしているとのことです。2018年には、約627,000人の女性が乳がんで死亡し、すなわち女性のがん死亡者全体の約15％を占めると推定されています。乳がんの罹患率は先進地域の女性で高いもの、世界的にはほぼすべての地域で罹患率が上昇しています。Extremity Tissue Expanderは、増加する乳がんの手術のための乳房インプラントを充填するための基本モデルです。したがって、乳がん有病率の上昇は、乳房再建セグメントの成長に寄与する主要な要因の1つです。

世界の四肢組織拡張器市場レポートでは、約40以上の市場データ表、45以上の図、180ページの構成で提供しています

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• 製品タイプ別市場内訳
• 製品形状別市場内訳
• アプリケーション別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳

第4章 市場力学

• 市場影響要因
• 促進要因
  • 技術的進歩
  • 先天性奇形の発生率の増加
  • 火傷や外傷の増加
• 抑制要因
  • 他の再建手術の利用可能性
• ビジネスチャンス
• 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• プライシング分析
• 法規制分析
• アンメットニーズ分析
• COVID-19影響度分析

第6章 製品タイプ別

• 下肢
• 上肢

第7章 製品形状別

• 長方形
• 三日月型
• アナトミカル
• 丸型
• その他

第8章 アプリケーション別

• 頭皮再建
• 乳房再建
• 口腔・顎顔面再建
• 小児科領域
• その他

第9章 エンドユーザー別

• 病院
• 美容クリニック
• 外来診療所
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東とアフリカ

第11章 競合情勢

• 競合シナリオ
• 市況ポジショニング／シェア分析
• M&A（合併・買収）分析

第12章 企業プロファイル

• Allergan PLC
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Mentor Worldwide LLC
• Eurosurgical Ltd.
• GC Aesthetics PLC
• Eurosilicone S.A.S.
• Laboratories Arion.
• Groupe Sebbin SAS
• Guangzhou Wanhe Plastic Materials Co. Ltd. Koken Co. Ltd
• Sientra, Inc.
• Koken Co. Ltd.（List Not Exhaustive）

第13章 DataM

Market Overview

Extremity Tissue Expanders Market is expected to grow at a high CAGR of 6% during the forecasting period (2022 - 2029). Tissue expansion is a process used by reconstructive surgeons to help the body grow new skin, bone, or other tissues. It is commonly used in adults and children for skin reconstruction. Extremity Tissue expanders are applicable for a variety of reconstructive problems, ranging from the treatment of congenital defects to the secondary reconstruction of extensive burn scars.

Tissue expanders have a similar function as a balloon. Initially, tissue expanders are relatively flat and filled with saline or air saline through a valve. This process puts pressure and promotes the growth of new tissue. These are mainly used for soft tissue expansion in cases of soft tissue and skin tumor. The outer layer of the expander is made up of silicone, and it is filled with saline water or silicone depending upon the requirement of the procedure. Mostly, tissue expanders are round or rectangular shaped, with 50 ccs to 1000 cc volume capability. Differential expanders and anatomical expanders are the two types of expanders used primarily to repair specific defects.

The Extremity Tissue Expanders Market study analysis offers an in-depth outlook on the market containing both quantitative, and qualitative data. It gives an outlook and forecast of the global market based on the Extremity Tissue Expanders Market segmentation by product type, product shape, application and end user. It also provides Extremity Tissue Expanders Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Market Dynamics

The global extremity tissue expanders market growth driven by certain factors such as technological advancements, rising incidence of congenital deformity, and the increasing number of burn and traumatic injuries are among the key factors driving the market growth.

An increasing number of plastic surgeries is expected to drive the global extremity tissue expanders market during the forecast period

According to the recent data of the American Society of Plastic Surgeons (ASPS), in 2018 among the 15.9 million cosmetic minimally-invasive procedures performed in the United States, Botulinum Toxin Type A tops the list with 7.44 million procedures. Many advanced non-surgical and minimally invasive aesthetic procedures were developed at the beginning of the 21st century. The increasing quality of care improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to the growth of procedural volume.

According to the American Society of Plastic Surgery, there were about 17.5 million minimally invasive cosmetic and surgical procedures performed in the U.S. in 2019. In North America, as per the National Clearinghouse of Plastic Surgery Procedural Statistics 2019, aesthetic breast surgeries witnessed an increase of 4.8% in the number of surgeries performed in 2019 as compared to the surgical procedures performed in 2016.

The American Society of Aesthetic Plastic Surgery (ASAPS) estimated 256,800 breast reduction surgeries and around 100,614 breast lift surgeries among U.S. women in the year 2019. The American Cancer Society (ACS), projected that 278,361 new cases of invasive breast cancer were diagnosed among women in 2019 in the U.S. Breast implantation is considered a significant procedure in the field of cosmetic surgery. The trend towards cosmetic surgeries provides a positive scope for extremity tissue expanders. The number of practice surgeons in reconstructive and cosmetic surgeries is also rising with time which will also boost the growth of the extremity tissue expanders market.

Stringent regulatory approvals hampering the growth of the extremity tissue expanders market

However, stringent regulatory approvals and guidelines related to the adoption of the extremity tissue expander, along with high treatment costs are some of the factors hampering the growth of this market during the forecast period.

Industry Analysis

The global extremity tissue expanders market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, clinical trials, pricing analysis, unmet needs.

Segmentation Analysis

The breast reconstruction segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The breast reconstruction segment is expected to grow at the fastest growth rate over the forecast period. Breast Cancer is one of the major types of cancer in women, which requires mastectomy for the removal of cancerous tissues. According to the WHO, breast cancer is the most frequent cancer among women, impacting 2.1 million women annually, and also causes the greatest number of cancer-related deaths among women. In 2018, it was estimated that about 627,000 women died from breast cancer, i.e. around 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally. Extremity Tissue expanders are the basic model to fill the breast implant for the growing number of surgeries for breast cancer. Hence, the rising prevalence of breast cancer prevalence is one of the major factors contributing to the growth of the breast reconstruction segment.

Geographical Analysis

North America region holds the largest market share of the global extremity tissue expanders market

The North American region is dominating the global extremity tissue expanders market accounted for the largest market share in 2019, owing to the rising prevalence of sports-related injuries, accidental causes, and burn cases. As per the U.S. Department of Health and Human Services, around two million people in the U.S. suffer from sports injuries annually.

In this region, the U.S. dominated the market in terms of revenue due to the presence of advanced healthcare infrastructure, increasing healthcare spending, and the widespread prevalence of various congenital disorders. As per the Centers for Disease Control and Prevention (CDC), 1 in every 33 babies born in the U.S. is affected by a birth defect. Besides, the rise in the number of reconstructive surgeries in the country has led to high demand for these products.

In North America, as per the 2019 statistics of International Society for Aesthetic Plastic Surgeons (ISAPS), there were about 1,795,551 breast augmentation procedures all over the world in 2019 which was more than any other performed aesthetic surgery. According to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States, the total number was 193,073 breast augmentation procedures in 2020. The increasing prevalence of breast cancer in North America will also complement the growth of the breast implant market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465: 28,026; and 29,929, respectively in 2020.

In Canada, the market is projected to grow at a significant growth rate during the forecast period, owing to a rise in the number of road accidents and trauma injuries which increases the demand for these expanders in leg and arm reconstruction procedures.

Competitive Landscape

The global extremity tissue expanders market is moderately competitive with few major players and small players. Some of the key players which are contributing to the growth of the market include Allergan PLC, Mentor Worldwide LLC, Eurosurgical Ltd., GC Aesthetics PLC, Eurosilicone S.A.S., Laboratories Arion, Groupe Sebbin SAS, Guangzhou Wanhe Plastic Materials Co. Ltd., Koken Co. Ltd, Sientra, Inc., Koken Co. Ltd., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the extremity tissue expanders market globally. For instance,

In June 2020, Allergan Aesthetics, an AbbVie company has initiated a new digital campaign to improve device tracking and further identify and reach breast implant patients who have, or have had, BIO CELL breast implants and/or tissue expanders to inform them of the risk of BIA-ALCL. Since July 2019 when the BIO CELL recall was announced, robust efforts were made to reach patients, however, the Company is still seeking to directly contact all U.S. BIO CELL patients that have not yet been notified. This is due to incomplete device tracking data for approximately 52,000 BIO CELL breast implant units.

In November 2016, Sientra, Inc., a medical aesthetics company, has acquired the complete portfolio of premium, differentiated tissue expanders from industry pioneer Specialty Surgical Products, Inc. (SSP). With this acquisition, Sientra adds to its product offering the AlloX2 and Dermaspan lines of breast tissue expanders, in addition to the Softspan line of extremity expanders. In 2019, Illumina acquired Pacific Biosciences, one of the leading providers of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.

Global Extremity Tissue Expanders Market - Key Companies to Watch

Allergan Plc

Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Product Portfolio: NATRELLE 133 Tissue Expanders- are designed as part of a system for breast reconstruction to create a pocket for placement of a NATRELLE breast implant.

The global extremity tissue expanders market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product Type
• 3.2. Market snippet by Product Shape
• 3.3. Market snippet by Application
• 3.4. Market Snippet by End-User
• 3.5. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
• 4.2. Drivers
  • 4.2.1. Technological advancements
  • 4.2.2. Rising incidence of congenital deformity
  • 4.2.3. The increasing number of burn and traumatic injuries
  • 4.2.4. XX
• 4.3. Restraints:
  • 4.3.1. Availability of other reconstructive surgeries
  • 4.3.2. XX
• 4.4. Opportunity
• 4.5. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. COVID-19 Impact Analysis

6. By Product Type

• 6.1. Introduction
• 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
• 6.3. Market Attractiveness Index, By Product Type Segment
  • 6.3.1. Lower Extremity*
    • 6.3.1.1. Introduction
    • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3.2. Upper Extremity

7. By Product Shape

• 7.1. Introduction
• 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
• 7.3. Market Attractiveness Index, By Product Shape Segment
  • 7.3.1. Rectangular*
    • 7.3.1.1. Introduction
    • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3.2. Crescent
  • 7.3.3. Anatomical
  • 7.3.4. Round
  • 7.3.5. Others

8. By Application

• 8.1. Introduction
• 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
• 8.3. Market Attractiveness Index, By Application Segment
  • 8.3.1. Scalp reconstruction*
    • 8.3.1.1. Introduction
    • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3.2. Breast reconstruction
  • 8.3.3. Oral and maxillofacial reconstruction
  • 8.3.4. Pediatrics
  • 8.3.5. Others

9. By End-User

• 9.1. Introduction
• 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
• 9.3. Market Attractiveness Index, By End-User Segment
  • 9.3.1. Hospitals*
    • 9.3.1.1. Introduction
    • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.3.2. Cosmetic Clinics
  • 9.3.3. Ambulatory Care Centers
  • 9.3.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. The U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. Australia
    • 10.5.7.5. Rest of Asia Pacific
• 10.6. The Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Allergan PLC*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Mentor Worldwide LLC
• 12.3. Eurosurgical Ltd.
• 12.4. GC Aesthetics PLC
• 12.5. Eurosilicone S.A.S.
• 12.6. Laboratories Arion.
• 12.7. Groupe Sebbin SAS
• 12.8. Guangzhou Wanhe Plastic Materials Co. Ltd. Koken Co. Ltd
• 12.9. Sientra, Inc.
• 12.10. Koken Co. Ltd. (List Not Exhaustive)

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us